pirfenidone has been researched along with Orphan Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrara, G; Ortiz, C; Pesonen, I | 1 |
| Furlow, B | 1 |
| Behr, J; Hoeper, MM; Klotsche, J; Kreuter, M; Pittrow, D; Wirtz, H | 1 |
1 review(s) available for pirfenidone and Orphan Diseases
| Article | Year |
|---|---|
[Characteristics and management of idiopathic pulmonary fibrosis: INSIGHTS-IPF registry].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Cross-Cultural Comparison; Cross-Sectional Studies; Female; Germany; Humans; Idiopathic Pulmonary Fibrosis; Lung; Male; Prognosis; Prospective Studies; Pyridones; Quality of Life; Randomized Controlled Trials as Topic; Rare Diseases; Registries; Sex Factors; Survival Analysis; Treatment Outcome | 2012 |
2 other study(ies) available for pirfenidone and Orphan Diseases
| Article | Year |
|---|---|
An Atypical Case of Idiopathic Pulmonary Fibrosis in a Patient from Africa.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Black People; Bronchoscopy; Diagnosis, Differential; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Hospitals, University; Humans; Idiopathic Pulmonary Fibrosis; Lung; Lung Diseases, Interstitial; Male; Pyridones; Rare Diseases; Respiratory Function Tests; Smokers; Sweden; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Pulmonary Fibrosis Foundation Summit 2015.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Clinical Trials as Topic; Congresses as Topic; Drug Approval; Enzyme Inhibitors; Humans; Indoles; Patient Selection; Pulmonary Fibrosis; Pyridones; Rare Diseases | 2016 |